Download Contraception Today: A Pocketbook for General Practitioners by Emeritus Professor of Family Planning and Reproductive PDF

By Emeritus Professor of Family Planning and Reproductive Health John Guillebaud

Past variations of this best-selling pocketbook were recognizedas the gold-standard introductory consultant to contraceptive perform. Thetarget viewers – basic practitioners and perform nurses – are oftenparticularly good put to o er strong contraceptive recommendation simply because theyalready understand the client’s wellbeing and fitness and conditions. This variation attracts onall most up-to-date assistance from WHO and the college of Sexual and ReproductiveHealth (FSRH) to provide a hugely sensible precis of each availablemethod of birth control within the united kingdom, and many of the components to beconsidered within the session.

Show description

Read or Download Contraception Today: A Pocketbook for General Practitioners and Practice Nurses PDF

Similar obstetrics & gynecology books

An atlas of gynecologic oncology

(Martin Dunitz) manhattan Univ. , manhattan urban. Atlas for postgraduates concerned with the surgical administration of gynecological malignancy. encompasses a complete description of nearly all of investigative and surgeries required of the gynecological oncologist. provides transparent written and pictorial guide.

Berek & Novak's Gynecology (Berek and Novak's Gynecology)

The most reliable textual content in gynecology is in its Fourteenth variation, completely revised and up-to-date and now in complete colour all through. prepared into 8 sections, this entire and common gynecological textbook offers counsel for the administration of particular gynecological stipulations. the 1st sections hide ideas of perform and preliminary evaluation and the appropriate simple technology.

Progestogens in Obstetrics and Gynecology

This booklet brings jointly the main updated information regarding the body structure of progestogens. This quantity addresses the bidirectional communique among hormones, fertility, tumors, and autoimmunity. It offers the fundamental technology and scientific views of progestogens that have no longer been formerly on hand in a single quantity.

Drugs During Pregnancy: Methodological Aspects

This publication addresses methodological facets of epidemiological stories on maternal drug use in being pregnant. Discussing the prevailing assets of mistakes and the way they could produce fallacious conclusions, it examines quite a few epidemiological concepts and assesses their strengths and weaknesses. those refer either to the identity of results (with unique emphasis on congenital malformations) and to the kinds of publicity (drug use).

Additional info for Contraception Today: A Pocketbook for General Practitioners and Practice Nurses

Sample text

G. in cancer, see text) as to make all-cause mortality in past-users the same or possibly even less than for never-users (see p. 22). Sources: Dinman BD. JAMA 1980; 244:1226–1228; Mills A, et al. BMJ 1996; 312:121; Anon. BMJ 1991; 302:743; Strom B. Pharmacoepidemiology. 2nd ed. ) by the current UK policy of generally commencing with a LNG product as first line, while being fully prepared to switch for symptom control upon request. In sum, the primary reason for choosing, or changing to, a more estrogenic product, such as one containing DSG or GSD as the progestogen, is for the control of side effects occurring on a LNG or NET product.

3d] [17/11/011/17:0:7] [13–77] Notes: 1. A single risk factor in the relative contraindication columns means preference for an LNG/NET Pill, if any COC used (as in the BNF). 2. Beware of synergism: more than one factor in either of relative contraindication columns. g. g. reduced mobility) condition normally means WHO 4 (do not use). 3. Acquired (non-hereditary) predispositions include positive results for antiphospholipid antibodies—definitely WHO 4 since they also increase the risk of arterial events (Table 6).

Other porphyrias are WHO 2, but a non-hormone method is usually preferable. Gallstones: symptomatic, medically treated (WHO 3, but WHO 2 if are an incidental finding; or after cholecystectomy). —and evidence supports COCs not causing depression). Diseases that require long-term treatment with enzyme-inducing drugs are WHO 3 [COC is usable (see below)—but alternative contraception is preferred]. Undiagnosed genital tract bleeding (WHO 3 until diagnosed and as necessary treated). e. WHO 4, 3 or 2) on COC prescription, and for many the data are unavailable.

Download PDF sample

Rated 4.50 of 5 – based on 30 votes